Centene Corporation presents a serious pattern of concern for government oversight, especially where public Medicaid and Medicare dollars are involved. The concern is not one isolated mistake. Public records, settlements, fines, lawsuits, sanctions, contract penalties, leadership restructuring, and financial instability show a repeated pattern of conduct that should raise questions about whether Centene is meeting the public trust required of a major government contractor.
Centene has paid or reserved massive sums related to Medicaid pharmacy benefit overbilling allegations. Ohio settled with Centene for $88.3 million over allegations that Centene and its pharmacy benefit operations overbilled the Ohio Medicaid program. Centene also announced no-fault agreements of $88 million for Ohio and $55 million for Mississippi, while denying liability.
Texas later reached a $165.6 million settlement with Centene over claims that it overcharged the state Medicaid program for pharmacy services. California reportedly reached a $215 million settlement, and Centene created a $1.25 billion reserve to address state pharmacy-benefit settlement exposure.
The problem appears national, not isolated. KFF Health News reported in 2025 that at least 20 states had settled with Centene over its pharmacy benefit manager operation connected to Medicaid prescription dr-g billing.
Florida should be especially concerned. Centene, through Sunshine Health, is Florida’s largest Medicaid managed care operator. Florida reached a $67 million settlement with Centene over allegations involving pharmacy benefit practices. Reporting also raised serious concerns that $10 million of the settlement was directed to the Hope Florida Foundation rather than being returned through the normal legislative process. Lawmakers questioned the legality, transparency, and oversight of that transfer.
Centene’s Florida Medicaid operations also have a history of contract penalties and sanctions. In 2022, Sunshine Health and StayWell, both owned by Centene, reportedly received approximately $11.7 million and $4.9 million in liquidated damages and sanctions, more than any other plans that year. The Sunshine Health amount included a $9.1 million sanction described as the largest sanction in the history of Florida’s statewide Medicaid managed care program.
Problems continued. In 2024, Florida regulators reportedly levied nearly $13.8 million in liquidated damages against Sunshine Health, far more than the next highest plan.
Federal Medicare oversight has also identified problems. CMS imposed a $2 million civil money penalty against Centene in January 2025 involving multiple Medicare Advantage and Part D contracts. CMS also imposed another civil money penalty in April 2025 involving multiple Centene Medicare contracts.
Centene has also faced shareholder litigation tied to its financial guidance and public statements. Multiple securities class action filings alleged that investors were misled during the period from December 12, 2024 through June 30, 2025, after Centene withdrew 2025 guidance. These allegations should concern government purchasers because financial instability, inaccurate forecasting, and investor litigation may affect staffing, claims processing, provider relations, and member services.
Centene’s leadership structure has also shifted significantly. In April 2026, Centene announced a new executive leadership structure, creating two new group president roles overseeing markets, commercial, Medicare, and specialty operations. In 2025, Centene also reduced board size after multiple board departures. These changes may be appropriate business decisions, but in the context of repeated sanctions, settlements, and financial volatility, they raise fair questions about continuity, accountability, and operational control.
Centene also offered voluntary separation packages to employees in 2026 following Medicaid and ACA marketplace pressures. Workforce reductions or buyouts at a government contractor should trigger close review when the contractor is responsible for vulnerable Medicaid, Medicare, behavioral health, child welfare, disability, and low-income populations.
The central issue for government is not whether Centene is profitable or large. The issue is whether Centene has shown a consistent pattern of problems while holding major public contracts. The public record supports several oversight concerns:
Centene has repeatedly settled Medicaid overbilling allegations across multiple states.
Centene’s Florida subsidiary has received substantial liquidated damages and sanctions.
CMS has imposed civil money penalties involving Medicare contracts.
Florida’s Centene settlement raised serious transparency concerns due to the Hope Florida payment structure.
Centene has faced securities litigation after withdrawing financial guidance.
Centene has undergone significant leadership and board changes.
Centene has implemented workforce separation efforts during a period of operational and financial pressure.
For these reasons, government officials should not treat Centene’s issues as isolated compliance events. The pattern warrants formal review, including contract performance audits, claims-payment audits, pharmacy-benefit audits, provider complaint review, member access review, behavioral health authorization review, staffing review, and examination of whether public funds were handled in a way that fully protected taxpayers and Medicaid recipients.
Recommended government action:
Require a full independent audit of Centene and Sunshine Health contract compliance.
Review all liquidated damages, sanctions, corrective action plans, and repeat violations.
Audit pharmacy benefit practices, rebate handling, spread pricing history, and subcontractor oversight.
Review provider payment delays, authorization denials, appeal outcomes, and network adequacy.
Examine whether staffing reductions or leadership changes affected contract performance.
Review the Florida $67 million settlement and determine whether all funds were handled according to law.
Require Centene to disclose all state and federal settlements, sanctions, penalties, corrective action plans, and pending litigation when bidding or renewing government contracts.
Consider enhanced monitoring, contract conditions, financial penalties, or procurement restrictions if repeated noncompliance is confirmed.
Centene is entrusted with public dollars and vulnerable lives. The available public record shows enough concern to justify aggressive oversight, not routine contract renewal without scrutiny.